B
Bioharvest Sciences Inc
OTC:CNVCF
Bioharvest Sciences Inc
OTC:CNVCF
Price:
5.1288
USD
-4.76%
Market Closed
Market Cap:
$87.5m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Bioharvest Sciences Inc
OTC:CNVCF
|
CA |
|
Rocket Doctor AI Inc
OTC:AIRDF
|
CA |
|
E
|
Embraer SA
NYSE:EMBJ
|
BR |
|
M
|
Mkango Resources Ltd
OTC:MKNGF
|
CA |
Income Statement
Earnings Waterfall
Bioharvest Sciences Inc
Bioharvest Sciences Inc
Income Statement
Bioharvest Sciences Inc
Bioharvest Sciences Inc
Currency: USD
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||
| Interest Expense |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
1
+68%
|
1
+56%
|
2
+57%
|
2
+29%
|
2
+18%
|
3
+17%
|
4
+30%
|
5
+45%
|
7
+27%
|
9
+27%
|
11
+19%
|
13
+20%
|
16
+25%
|
19
+21%
|
22
+17%
|
|
| Gross Profit | |||||||||||||||||
| Cost of Revenue |
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(3)
|
(4)
|
(5)
|
(6)
|
(7)
|
(7)
|
(8)
|
(9)
|
(10)
|
|
| Gross Profit |
0
N/A
|
0
+54%
|
0
+48%
|
0
+57%
|
1
+35%
|
1
+14%
|
1
-2%
|
1
+10%
|
1
+48%
|
2
+50%
|
3
+55%
|
4
+41%
|
6
+41%
|
8
+39%
|
10
+25%
|
12
+23%
|
|
| Operating Income | |||||||||||||||||
| Operating Expenses |
(6)
|
(7)
|
(9)
|
(10)
|
(9)
|
(10)
|
(10)
|
(10)
|
(12)
|
(12)
|
(14)
|
(14)
|
(16)
|
(17)
|
(18)
|
(20)
|
|
| Selling, General & Administrative |
(4)
|
(6)
|
(7)
|
(8)
|
(5)
|
(5)
|
(6)
|
(6)
|
(9)
|
(10)
|
(11)
|
(11)
|
(12)
|
(13)
|
(14)
|
(16)
|
|
| Research & Development |
(1)
|
(1)
|
(2)
|
(2)
|
(4)
|
(4)
|
(4)
|
(4)
|
(2)
|
(2)
|
(3)
|
(3)
|
(3)
|
(4)
|
(4)
|
(4)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
|
| Operating Income |
(6)
N/A
|
(7)
-27%
|
(9)
-22%
|
(10)
-13%
|
(8)
+12%
|
(9)
-5%
|
(9)
-1%
|
(9)
-3%
|
(11)
-15%
|
(11)
+1%
|
(11)
-4%
|
(10)
+9%
|
(10)
0%
|
(9)
+11%
|
(8)
+12%
|
(8)
-1%
|
|
| Pre-Tax Income | |||||||||||||||||
| Interest Income Expense |
(0)
|
(6)
|
(1)
|
(1)
|
(1)
|
4
|
(0)
|
(1)
|
1
|
1
|
1
|
2
|
(1)
|
(10)
|
(8)
|
(9)
|
|
| Non-Reccuring Items |
(1)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(7)
N/A
|
(13)
-99%
|
(10)
+24%
|
(11)
-12%
|
(10)
+12%
|
(5)
+48%
|
(9)
-81%
|
(10)
-9%
|
(11)
-10%
|
(10)
+12%
|
(10)
-5%
|
(8)
+21%
|
(13)
-54%
|
(18)
-46%
|
(16)
+12%
|
(17)
-6%
|
|
| Net Income | |||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(7)
|
(13)
|
(10)
|
(11)
|
(10)
|
(5)
|
(9)
|
(10)
|
(11)
|
(10)
|
(10)
|
(8)
|
(13)
|
(18)
|
(16)
|
(17)
|
|
| Net Income (Common) |
(7)
N/A
|
(13)
-99%
|
(10)
+24%
|
(11)
-12%
|
(10)
+12%
|
(5)
+48%
|
(9)
-81%
|
(10)
-9%
|
(11)
-10%
|
(10)
+12%
|
(10)
-5%
|
(8)
+21%
|
(13)
-54%
|
(18)
-46%
|
(16)
+12%
|
(17)
-6%
|
|
| EPS (Diluted) |
-0.02
N/A
|
-0.03
-50%
|
-0.02
+33%
|
-0.03
-50%
|
-0.79
-2 533%
|
-0.01
+99%
|
-0.02
-100%
|
-0.02
N/A
|
-0.86
-4 200%
|
-0.02
+98%
|
-0.02
N/A
|
-0.6
-2 900%
|
-0.93
-55%
|
-1.33
-43%
|
-0.99
+26%
|
-0.99
N/A
|
|
Switch to:
Switch to:
See Also
Discover More
